Clinical Trials Directory

Trials / Completed

CompletedNCT02835781

Acellular Dermal Matrix in Breast Reconstruction

Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University Hospital Bratislava · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Allogenic acellular dermal matrix has been used in burn injuries or abdominal walls reconstructions. However, it is solely used in breast reconstructions after breast carcinoma amputation. The efficacy of such allogenic dermal matrix can be advantageous when compared to current treatment options, however, this has to be proved.

Detailed description

This is a prospective study, where patients undergoing breast reconstruction surgery using acellular dermal matrix (ADM) with expander use in first phase of reconstruction will be included. The permanent breast implants will be implanted approximately half year during second surgery. Acellular dermal matrix is a soft tissue graft that is formed by decellularization, however with intact extracellular dermal matrix. Such structure is able to re-create adequate skeleton for host cells with subsequent incorporation and revascularization. The safety and appropriateness of such ADM in breast reconstruction surgery will be analyzed.

Conditions

Interventions

TypeNameDescription
OTHERAcellular dermal matrix implantationAcellular dermal matrix obtained from Central tissue bank, University Hospital Bratislava, will be used for acellular dermal matrix implantation.

Timeline

Start date
2010-01-01
Primary completion
2014-01-01
Completion
2016-06-01
First posted
2016-07-18
Last updated
2016-07-18

Locations

1 site across 1 country: Slovakia

Source: ClinicalTrials.gov record NCT02835781. Inclusion in this directory is not an endorsement.